Triple combination therapy shows promise against a rare, deadly asbestos cancer

New discovery could lead to therapies for patients with Duchenne muscular dystrophy
14 April 2021
Most young people eager for COVID-19 vaccine, poll shows
14 April 2021

Triple combination therapy shows promise against a rare, deadly asbestos cancer

Combining immune-boosting drugs with radiation and surgery increased the survival and anticancer immune response in mouse models of mesothelioma in preclinical research by Princess Margaret Cancer Centre researchers.

Comments are closed.